Abbott Medical Devices
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Abbott Medical Devices sits in the top decile of US sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count).
Abbott Medical Devices: 261 sponsored US clinical trials, 23 recruiting.
Abbott Medical Devices sponsors 261 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 186 completed. 17 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 15 trials.
Top-decile sponsor footprint
Abbott Medical Devices ranks in the top decile of sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
186 of 211 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
261 total, page 1 of 6
A Post-Market Assessment of the Safety and Performance of the TriClip™ System
NCT07586995
Agilis RF TSP Early Feasibility Study
NCT07361445
Abbott Cephea Mitral Valve Disease Registry
NCT07069673
TriClip CED RWE Study
NCT06920745
TECTONIC CAD IVL IDE Study
NCT06885177
CardioMEMS HF System Coverage with Evidence Development Study
NCT06779552
ViewFlex X ICE First-in-Human Study
NCT06772493
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195
Esprit BTK Post-Approval Study
NCT06656364
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
NCT06423430
Abbott Structural Heart Device Registry
NCT06590467
Aveir AR Coverage With Evidence Development (CED) Study
NCT06100770
AVEIR DR Coverage With Evidence Development (CED) Study
NCT05932602
Aveir DR Real-World Evidence Post-Approval Study
NCT05935007
External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)
NCT05537662
Aveir VR Real-World Evidence Post-Approval Study
NCT05270499
Aveir VR Coverage With Evidence Development Post-Approval Study
NCT05336877
Cephea Early Feasibility Study
NCT05061004
Valved Graft PMCF Study
NCT04754217
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
NCT04761120
Abbott Vascular Medical Device Registry
NCT04573660
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
NCT03876054
Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis
NCT07116551
ASCEND CSP IDE Study
NCT06830746
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:
NCT06676072
Abbott Medical - VERITAS Study
NCT06707688
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
NCT06172699
Abbott Ventricular Tachycardia PAS
NCT05839873
Amulet™ ADVANCE LAA
NCT05997446
Abbott Atrial Fibrillation Post Approval Study
NCT05434650
XIENCE Skypoint Large Vessel Post Approval Study
NCT05423379
Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation
NCT05269862
LIFE-BTK PK Sub-study
NCT05208905
Aveir DR i2i Study
NCT05252702
PARADIGM: Amplatzer Valvular Plug for PVL Closure
NCT04489823
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
NCT04559945
LIFE-BTK Randomized Controlled Trial
NCT04227899
MitraClip REPAIR MR Study
NCT04198870
Amplatzer Amulet LAAO vs. NOAC
NCT04226547
JETi Lower Extremity Venous Thrombosis
NCT07027878
MitraClip EXPAND G4 Study
NCT04177394
SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
NCT03924661
SyncAV Post-Market Trial
NCT04100148
Portico Next Generation Approval Study
NCT04011722
TRILUMINATE Pivotal Trial
NCT03904147
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
NCT03433274
Confirm Rx Insertable Cardiac Monitor SMART Registry
NCT03505801
AMPLATZER PFO Occluder Post Approval Study
NCT03309332
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
NCT02000115
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
| Phase 3 | 11 |
| Phase 4 | 6 |
Therapeutic Areas
Where Abbott Medical Devices enrollment is open (later-stage tilt)
23 recruiting of 261 indexed (9% open); 186 completed (71%).
Phase mix: 17 late (III/IV) vs 5 early (I/II) (later-stage heavy).
Top condition: Heart Failure (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Abbott Medical Devices: open-pipeline peers nationwide
Peers matched on 261 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 261 trials (± recruiting share)
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
- Novartis · 265 trials · 0% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Boston Medical Center · 253 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Grifols Therapeutics · 9% recruiting · 34 trials
- Butler Hospital · 9% recruiting · 103 trials
- AMAG Pharmaceuticals · 9% recruiting · 23 trials
- Iowa State University · 9% recruiting · 23 trials
Related
What to do with this Abbott Medical Devices page
261 registered trials is a research-attention snapshot, not an endorsement of Abbott Medical Devices or any single study.
- 23 of Abbott Medical Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Abbott Medical Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Abbott Medical Devices pipeline card: 261 registered trials from official public datasets.Report a data error.